Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
+0.00%
trims when stocks drop
when a holding falls −10%+
Middle response
+0.00%
baseline attrition
Rally response
+0.00%
adds into rallies
when a holding rises +10%+
Top positions · 9
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| MGTXMeiraGTx Holdings plc | $106M | 31.4% | +27.7% | 1.5 yr |
| — | $78M | 23.2% | — | 1.5 yr |
| NVAXNovavax, Inc. | $56M | 16.7% | +27.0% | 1.5 yr |
| ANABAnaptysBio, Inc. | $30M | 9.0% | +198.4% | 1.5 yr |
| AGMBAgomAb Therapeutics N.V. | $29M | 8.7% | — | 0.3 yr |
| MPLTMapLight Therapeutics, I | $19M | 5.5% | — | 0.5 yr |
| IMRXImmuneering Corporation | $14M | 4.2% | +246.7% | 0.8 yr |
| ELDNEledon Pharmaceuticals, | $3M | 0.7% | -9.1% | 1.5 yr |
| QTTBQ32 Bio Inc. | $2M | 0.5% | +289.1% | 1.5 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology76.8%-13.4pp$258M
Unknown23.2%+13.4pp$78M
Country
US68.1%-20.6pp
Unknown23.2%+13.4pp
BE8.7%
Top 5: 89.0% · Top 10: 100.0% · Top 25: 100.0%
Winners
| Ticker | Prev $ | PnL | YoY % |
|---|---|---|---|
| MGTX | $83M | +0.02B | 27.7% |
| ANAB | $15M | +0.02B | 198.4% |
| NVAX | $44M | +0.01B | 27.0% |
| QTTB | $0M | +0.00B | 289.1% |
| ELDN | $3M | -0.00B | -9.1% |
Losers
| Ticker | Prev $ | PnL | YoY % |
|---|---|---|---|
| ELDN | $3M | -0.00B | -9.1% |
Top buys this quarter · 1
| AGMB AgomAb Therapeutics N.V. Amerinew | +$29M |
Top sells this quarter · 0
No sells this quarter
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $336M | 9 | +37.22% | +17.59% | +19.63% | -0.01B |
| 2025-12-31 | $310M | 8 | +22.49% | +17.72% | +4.77% | +0.06B |
| 2025-09-30 | $260M | 9 | +32.09% | +8.12% | +23.97% | +0.03B |
| 2025-06-30 | $176M | 10 | -1.81% | +10.78% | -12.59% | +0.01B |
| 2025-03-31 | $166M | 9 | -0.64% | -4.27% | +3.63% | -0.01B |
| 2024-12-31 | $174M | 9 | — | — | — | — |